Valuation Update With 7 Day Price Move • Jul 20
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩1,127, the stock trades at a trailing P/E ratio of 25x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total loss to shareholders of 33% over the past three years. Valuation Update With 7 Day Price Move • Jul 02
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₩935, the stock trades at a trailing P/E ratio of 20.8x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 50% over the past three years. New Risk • Jun 08
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₩14.9b (US$9.56m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₩14.9b market cap, or US$9.56m). Minor Risk Large one-off items impacting financial results. New Risk • May 26
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 27% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₩19.4b market cap, or US$12.8m). Valuation Update With 7 Day Price Move • Apr 01
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩1,039, the stock trades at a trailing P/E ratio of 17.2x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total loss to shareholders of 38% over the past three years. Tillkännagivande • Feb 27
NPK Co.,Ltd, Annual General Meeting, Mar 27, 2026 NPK Co.,Ltd, Annual General Meeting, Mar 27, 2026, at 10:00 Tokyo Standard Time. Location: conference room, 7, okgye2gongdan-ro 5-gil, gyeongsangbuk-do, gumi South Korea Upcoming Dividend • Dec 22
Upcoming dividend of ₩30.00 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 24 April 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 3.1%. Lower than top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (1.3%). Declared Dividend • Nov 08
Dividend of ₩30.00 announced Dividend of ₩30.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 24th April 2026 Dividend yield will be 2.8%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 6 years but payments have been stable during that time. Tillkännagivande • Nov 07
NPK Co.,Ltd announces Annual dividend, payable on April 24, 2026 NPK Co.,Ltd announced Annual dividend of KRW 30.0000 per share payable on April 24, 2026, ex-date on December 29, 2025 and record date on December 31, 2025. New Risk • Mar 26
New major risk - Dividend sustainability The dividend is not well covered by earnings and cash flows. The company is paying a dividend despite being loss-making. The company is paying a dividend despite having no free cash flows. Dividend yield: 2.9% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Earnings have declined by 3.6% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩19.5b market cap, or US$13.3m). Tillkännagivande • Feb 27
NPK Co.,Ltd, Annual General Meeting, Mar 27, 2025 NPK Co.,Ltd, Annual General Meeting, Mar 27, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 7, okgye2gongdan-ro 5-gil, gyeongsangbuk-do, gumi South Korea Upcoming Dividend • Dec 20
Upcoming dividend of ₩30.00 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 23 April 2025. The company is not currently making a profit but it is cash flow positive. Trailing yield: 2.7%. Lower than top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (2.2%). New Risk • Dec 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (₩19.8b market cap, or US$13.8m). New Risk • Dec 07
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended September 2013. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2013 fiscal period end). Minor Risk Market cap is less than US$100m (₩18.9b market cap, or US$13.3m). Reported Earnings • Mar 21
Full year 2023 earnings released: EPS: ₩91.00 (vs ₩67.37 in FY 2022) Full year 2023 results: EPS: ₩91.00 (up from ₩67.37 in FY 2022). Revenue: ₩63.0b (down 3.4% from FY 2022). Net income: ₩1.71b (up 36% from FY 2022). Profit margin: 2.7% (up from 1.9% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 7% per year whereas the company’s share price has fallen by 4% per year. Upcoming Dividend • Dec 20
Upcoming dividend of ₩30.00 per share at 1.5% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 22 April 2024. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 1.5%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%). Reported Earnings • Nov 19
Third quarter 2023 earnings released: EPS: ₩42.00 (vs ₩0.20 in 3Q 2022) Third quarter 2023 results: EPS: ₩42.00 (up from ₩0.20 in 3Q 2022). Revenue: ₩16.2b (up 26% from 3Q 2022). Net income: ₩793.6m (up ₩789.9m from 3Q 2022). Profit margin: 4.9% (up from 0% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has remained flat. Upcoming Dividend • Dec 21
Upcoming dividend of ₩30.00 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 21 April 2023. Payout ratio is a comfortable 21% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%). Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. 1 independent director (2 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Jun 23
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₩1,790, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total loss to shareholders of 14% over the past three years. Valuation Update With 7 Day Price Move • May 10
Investor sentiment improved over the past week After last week's 16% share price gain to ₩2,605, the stock trades at a trailing P/E ratio of 23.2x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 25% over the past three years. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. 1 independent director (2 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Jan 04
Investor sentiment improved over the past week After last week's 31% share price gain to ₩2,740, the stock trades at a trailing P/E ratio of 34.1x. Average trailing P/E is 17x in the Chemicals industry in South Korea. Total returns to shareholders of 50% over the past three years. Upcoming Dividend • Dec 22
Upcoming dividend of ₩30.00 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 22 April 2022. Payout ratio is a comfortable 37% and the cash payout ratio is 84%. Trailing yield: 1.5%. Lower than top quartile of South Korean dividend payers (2.4%). In line with average of industry peers (1.5%). Valuation Update With 7 Day Price Move • Oct 12
Investor sentiment improved over the past week After last week's 16% share price gain to ₩2,180, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 19x in the Chemicals industry in South Korea. Total returns to shareholders of 15% over the past three years. Is New 90 Day High Low • Jan 19
New 90-day high: ₩2,175 The company is up 21% from its price of ₩1,800 on 21 October 2020. The South Korean market is up 26% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 35% over the same period. Is New 90 Day High Low • Dec 04
New 90-day high: ₩1,990 The company is up 30% from its price of ₩1,525 on 04 September 2020. The South Korean market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. Is New 90 Day High Low • Nov 18
New 90-day high: ₩1,890 The company is up 28% from its price of ₩1,475 on 20 August 2020. The South Korean market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. Is New 90 Day High Low • Oct 28
New 90-day high: ₩1,835 The company is up 3.0% from its price of ₩1,775 on 30 July 2020. The South Korean market is up 2.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 18% over the same period. Is New 90 Day High Low • Oct 12
New 90-day high: ₩1,820 The company is up 8.0% from its price of ₩1,690 on 14 July 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 30% over the same period.